|
1
|
Hodgson TA and Cai L: Medical care
expenditures for hypertension, its complications, and its
comorbidities. Medical Care. 39:599–615. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ponticos M and Smith BD: Extracellular
matrix synthesis in vascular disease: Hypertension, and
atherosclerosis. J Biomed Res. 28:25–39. 2014.PubMed/NCBI
|
|
3
|
Rizzoni D and Agabiti-Rosei E: Structural
abnormalities of small resistance arteries in essential
hypertension. Intern Emerg Med. 7:205–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang NP, Li H, Qiu YL, Zhou GM, Wang Y, Ma
J and Mei QB: The effects of microgravity on blood vessels and
vascular endothelial cells. Sheng Li Ke Xue Jin Zhan. 45:385–390.
2014.(In Chinese). PubMed/NCBI
|
|
5
|
Bali A and Jaggi AS: Angiotensin
II-triggered kinase signaling cascade in the central nervous
system. Rev Neurosci. 27:301–315. 2016.PubMed/NCBI
|
|
6
|
Zimmerman MC, Lazartigues E, Lang JA,
Sinnayah P, Ahmad IM, Spitz DR and Davisson RL: Superoxide mediates
the actions of angiotensin II in the central nervous system. Circ
Res. 91:1038–1045. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Becari C, Oliveira EB and Salgado MC:
Alternative pathways for angiotensin II generation in the
cardiovascular system. Braz J Med Biol Res. 44:914–919. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Naik P, Murumkar P, Giridhar R and Yadav
MR: Angiotensin II receptor type 1 (AT1) selective nonpeptidic
antagonists-a perspective. Bioorg Med Chem. 18:8418–8456. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Messerli FH and Bangalore S: Angiotensin
receptor blockers reduce cardiovascular events, including the risk
of myocardial infarction. Circulation. 135:2085–2087. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li W, Sullivan MN, Zhang S, Worker CJ,
Xiong Z, Speth RC and Feng Y: Intracerebroventricular infusion of
the (Pro)renin receptor antagonist PRO20 attenuates
deoxycorticosterone acetate-salt-induced hypertension.
Hypertension. 65:352–361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li XC and Zhuo JL: Recent updates on the
proximal tubule Renin-angiotensin system in angiotensin
II-Dependent hypertension. Curr Hypertens Rep. 18:632016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gonzalez AA, Lara LS, Luffman C, Seth DM
and Prieto MC: Soluble form of the (pro)renin receptor is augmented
in the collecting duct and urine of chronic angiotensin
II-dependent hypertensive rats. Hypertension. 57:859–864. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morimoto S, Ando T, Niiyama M, Seki Y,
Yoshida N, Watanabe D, Kawakami-Mori F, Kobori H, Nishiyama A and
Ichihara A: Serum soluble (pro)renin receptor levels in patients
with essential hypertension. Hypertens Res. 37:642–648. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Castoldi G, Di Gioia CR, Bombardi C,
Catalucci D, Corradi B, Gualazzi MG, Leopizzi M, Mancini M, Zerbini
G, Condorelli G, et al: MiR-133a regulates collagen 1A1: Potential
role of miR-133a in myocardial fibrosis in angiotensin II-dependent
hypertension. J Cell Physiol. 227:850–856. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Peng H, Mehaffey EP, Kimball CD,
Grobe JL, van Gool JM, Sullivan MN, Earley S, Danser AH, Ichihara A
and Feng Y: Neuron-specific (pro)renin receptor knockout prevents
the development of salt-sensitive hypertension. Hypertension.
63:316–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gonzalez AA and Prieto MC: Roles of
collecting duct renin and (pro)renin receptor in hypertension: Mini
review. Ther Adv Cardiovasc Dis. 9:191–200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNA target recognition and
regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kriegel AJ, Baker MA, Liu Y, Liu P, Cowley
AW Jr and Liang M: Endogenous microRNAs in human microvascular
endothelial cells regulate mRNAs encoded by hypertension-related
genes. Hypertension. 66:793–799. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dorn GW II: MicroRNAs in cardiac disease.
Transl Res. 157:226–235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kontaraki JE, Marketou ME, Parthenakis FI,
Maragkoudakis S, Zacharis EA, Petousis S, Kochiadakis GE and Vardas
PE: Hypertrophic and antihypertrophic microRNA levels in peripheral
blood mononuclear cells and their relationship to left ventricular
hypertrophy in patients with essential hypertension. J Am Soc
Hypertens. 9:802–810. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matkovich SJ, Wang W, Tu Y, Eschenbacher
WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM and Dorn GW II:
MicroRNA-133a protects against myocardial fibrosis and modulates
electrical repolarization without affecting hypertrophy in
pressure-overloaded adult hearts. Circ Res. 106:166–175. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y, Huang A, Li T, Su X, Ding H, Li H,
Qin X, Hou L, Zhao Q, Ge X, et al: MiR-152 reduces human umbilical
vein endothelial cell proliferation and migration by targeting
ADAM17. FEBS Lett. 588:2063–2069. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han G, Wei Z, Cui H, Zhang W, Wei X, Lu Z
and Bai X: NUSAP1 gene silencing inhibits cell proliferation,
migration and invasion through inhibiting DNMT1 gene expression in
human colorectal cancer. Exp Cell Res. 367:216–221. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shan H, Zhang S, Wei X, Li X, Qi H, He Y,
Liu A, Luo D and Yu X: Protection of endothelial cells against Ang
II-induced impairment: Involvement of both PPARa and PPARγ via
PI3K/Akt pathway. Clin Exp Hypertens. 38:571–577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pourgholami MH, Khachigian LM, Fahmy RG,
Badar S, Wang L, Chu SW and Morris DL: Albendazole inhibits
endothelial cell migration, tube formation, vasopermeability, VEGF
receptor-2 expression and suppresses retinal neovascularization in
ROP model of angiogenesis. Biochem Biophys Res Commun. 397:729–734.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gkaliagkousi E, Gavriilaki E,
Triantafyllou A and Douma S: Clinical Significance of endothelial
dysfunction in essential hypertension. Curr Hypertens Rep.
17:852015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Poliseno L, Tuccoli A, Mariani L,
Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S and
Rainaldi G: MicroRNAs modulate the angiogenic properties of HUVECs.
Blood. 108:3068–3071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ooi JY, Bernardo BC and Mcmullen JR: The
therapeutic potential of miRNAs regulated in settings of
physiological cardiac hypertrophy. Future Med Chem. 6:205–222.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Biancardi VC, Bomfim GF, Reis WL,
Al-Gassimi S and Nunes KP: The interplay between Angiotensin II,
TLR4 and hypertension. Pharmacol Res. 120:88–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cha SA, Park BM and Kim SH:
Angiotensin-(1–9) ameliorates pulmonary arterial hypertension via
angiotensin type II receptor. Korean J Physiol Pharmacol.
22:447–456. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Condorelli G, Latronico MV and Cavarretta
E: microRNAs in cardiovascular diseases: Current knowledge and the
road ahead. J Am Coll Cardiol. 63:2177–2187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dluzen DF, Kim Y, Bastian P, Zhang Y,
Lehrmann E, Becker KG, Noren Hooten N and Evans MK: MicroRNAs
modulate oxidative stress in hypertension through PARP-1
regulation. Oxid Med Cell Longev. 2017:39842802017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang T: Crosstalk between (Pro)renin
receptor and COX-2 in the renal medulla during angiotensin
II-induced hypertension. Curr Opin Pharmacol. 21:89–94. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Williamson CR, Khurana S, Nguyen P, Byrne
CJ and Tai TC: Comparative analysis of renin-angiotensin system
(RAS)-related gene expression between hypertensive and normotensive
rats. Med Sci Monit Basic Res. 23:20–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang L, Zhu Q, Lu A, Liu X, Zhang L, Xu C,
Liu X, Li H and Yang T: Sodium butyrate suppresses angiotensin
II-induced hypertension by inhibition of renal (pro)renin receptor
and intrarenal renin-angiotensin system. J Hypertens. 35:1899–1908.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Christodoulatos GS and Dalamaga M:
Micro-RNAs as clinical biomarkers and therapeutic targets in breast
cancer: Quo vadis? World J Clin Oncol. 5:71–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lauressergues D, Couzigou JM, Clemente HS,
Martinez Y, Dunand C, Bécard G and Combier JP: Primary transcripts
of microRNAs encode regulatory peptides. Nature. 520:90–93. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sharma NM, Nandi SS, Zheng H, Mishra PK
and Patel KP: A novel role for miR-133a in centrally mediated
activation of the renin-angiotensin system in congestive heart
failure. Am J Physiol Heart Circ Physiol. 312:H968–H979. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Haque R, Hur EH, Farrell AN, Iuvone PM and
Howell JC: MicroRNA-152 represses VEGF and TGFβ1 expressions
through post-transcriptional inhibition of (Pro)renin receptor in
human retinal endothelial cells. Mol Vis. 21:224–235.
2015.PubMed/NCBI
|
|
41
|
Wang Y, Lumbers ER, Arthurs AL, Corbisier
de Meaultsart C, Mathe A, Avery-Kiejda KA, Roberts CT, Pipkin FB,
Marques FZ, et al: Regulation of the human placental (pro)renin
receptor-prorenin-angiotensin system by microRNAs. Mol Hum Reprod.
24:453–464. 2018.PubMed/NCBI
|
